6 protocols meet the specified criteria
- OCR18503
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
- OCR24823
LAM-2018-01 Prospective Clinical Trial to Detect Liver Cancer through Quantification of cfDNA Methylation in Blood Samples (CLiMB)
- OCR28503
Glycotest G-1001 Case-Control Study of the Glycotest HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
- OCR38884
NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE)-PHASE 2 SUBPROTOCOL OF TIPIFARNIB IN PATIENTS WITH TUMORS HARBORING HRAS GENOMIC ALTERATIONS
- OCR39825
An Open-Label Study of Regorafenib in Combination with Pembrolizumab in Patients with Advanced or Metastatic Hepatocellular Carcinoma (HCC) after PD-1/PD-L1 Immune Checkpoint Inhibitors
- OCR40539
Point-of-care Intervention to Address Financial Toxicity in Patients with Cancer: Provider Interviews